Immuneering Corporation (IMRX) Discusses Positive Atebimetinib ASCO Data Update in First ...

Immuneering Corporation ( IMRX) Discusses Positive Atebimetinib ASCO Data Update in First-Line Pancreatic Cancer June 1, 2026 8:00 AM EDT ...
ascopubs.org

Prospective Validation of Circulating Tumor DNA Measurable Residual Disease After First ...

Automated Lymph Node and Extranodal Extension Assessment Improves Risk Stratification in Oropharyngeal Carcinoma Patients were enrolled in the HOVON-902 prospective cohort and received curative-intent ...